Salmeterol Xinafoate



Salmeterol Xinafoate





(sal mee’ ter ol ze inn ah foh’ ate)

Serevent Diskus

PREGNANCY CATEGORY C


Drug Classes

Antiasthmatic

Beta2-selective adrenergic agonist


Therapeutic Actions

Long-acting agonist that binds to beta2 receptors in the lungs, causing bronchodilation; also inhibits the release of inflammatory mediators in the lungs, blocking swelling and inflammation.


Indications



  • Maintenance therapy for asthma and prevention of bronchospasm in patients 4 yr and older with reversible obstructive airway disease including nocturnal asthma


  • Long-term maintenance treatment of bronchospasm related to COPD


  • Prevention of exercise-induced bronchospasm in patients 4 yr and older



Available Forms

Inhalation powder—50 mcg (Diskus)


Dosages

Adults and patients 12 yr and older



  • Asthma or bronchospasm: 1 inhalation (50 mcg) bid at 12-hr intervals.


  • Exercise-induced asthma: 1 inhalation 30 min or more before exertion.


  • COPD: 1 inhalation (50 mcg) bid at 12-hr intervals.

Pediatric patients 4–12 yr

Jul 21, 2016 | Posted by in NURSING | Comments Off on Salmeterol Xinafoate

Full access? Get Clinical Tree

Get Clinical Tree app for offline access